Theralink Technologies, Inc.
THER
Rank in Stocks
#33346
Theralink Technologies, Inc., headquartered in Golden, Colorado, is a... Theralink Technologies, Inc., headquartered in Golden, Colorado, is a commercial-stage enterprise specializing in precision medicine and the generation of crucial molecular data. The company is dedicated to advancing and bringing to market innovative cancer immunotherapy products. Utilizing its proprietary platform, which focuses on phosphoprotein and protein biomarkers, alongside its sophisticated laboratory-developed test (LDT) technology, Theralink addresses diverse aspects of oncology and pharmaceutical research. Through their specialized Theralink Reverse Phase Protein Array assays, they provide highly accurate oncology data. This information enables the biopharmaceutical industry and clinical oncologists to more precisely predict which patients will respond to, or be resistant to, both FDA-approved and investigational drug treatments. Ultimately, Theralink's diagnostic assays deliver vital, actionable insights that benefit physicians, patients, and biopharmaceutical companies operating within the field of cancer care. The company adopted its current name, Theralink Technologies, Inc., in September 2020, having previously operated as OncBioMune Pharmaceuticals, Inc.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$615.15K
Change (1 day)
0.00%
Change (1 year)
9,900.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Theralink Technologies, Inc. (THER)
Category
Healthcare
EPS for Theralink Technologies, Inc. (THER)
EPS as of September 2023 TTM: $-0.01
According to Theralink Technologies, Inc.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2023 the company had an EPS of $-0.50, a decrease compared to its 2022 EPS of $-0.22.
EPS history for Theralink Technologies, Inc. from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -97.28% |
| 2023 | $-0.50 | 127.27% |
| 2022 | $-0.22 | 120.00% |
| 2021 | $-0.10 | -97.36% |
| 2020 | $-3.79 | -83.25% |
| 2019 | $-22.63 | -209.11% |
| 2018 | $20.74 | -117.37% |
| 2017 | $-119.37 | 360.71% |
| 2016 | $-25.91 | 71.82% |
| 2015 | $-15.08 | 8.33% |
| 2014 | $-13.92 | -97.37% |
| 2013 | $-528.32 | -66.83% |
| 2012 | $-1.59K | -9.20% |
| 2011 | $-1.75K | 1,672.41% |
| 2010 | $-98.98 | 7.87% |
| 2009 | $-91.76 | -59.74% |
| 2008 | $-227.91 | 28.53% |
| 2007 | $-177.32 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -115,247.06% |
US
|
|
| $-7.07 | 51,885.29% |
US
|
|
| $-5.29 | 38,797.06% |
AU
|
|
| $12.88 | -94,806.62% |
BE
|
|
| $21.56 | -158,629.41% |
NL
|
Questions about Theralink Technologies, Inc.'s earnings per share (EPS)
What is Theralink Technologies, Inc.'s earnings per share (EPS)?
Theralink Technologies, Inc.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Sep 2023.
What was Theralink Technologies, Inc.'s earnings per share (EPS) in 2023?
In 2023, Theralink Technologies, Inc.'s earnings per share (EPS) was $-0.50, compared with $-0.22 in 2022.
How has Theralink Technologies, Inc.'s earnings per share (EPS) changed since 2018?
From 2018 to 2023, Theralink Technologies, Inc.'s earnings per share (EPS) was highest in 2018 ($20.74) and lowest in 2019 ($-22.63).
How does Theralink Technologies, Inc.'s earnings per share (EPS) compare with similar companies?
Theralink Technologies, Inc.'s earnings per share (EPS) ($-0.01) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.